Patents by Inventor Julien Peetermans

Julien Peetermans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminum phosphate
    Patent number: 6756040
    Abstract: The invention relates to a vaccine formulation for the prevention of Haemophilus Influenzae Type B (Hib) infections and where the antigen is adsorbed onto aluminum phosphate. The invention also relates to a multivalent vaccines, that is a vaccine for the amelioration or treatment of more than one disease states. The present invention also relates to the production and use of such vaccines in medicine.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: June 29, 2004
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventors: Julien Peetermans, Pierre Hauser
  • Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
    Publication number: 20020182226
    Abstract: The invention relates to a vaccine formulation for the prevention of Haemophilus Influenzae Type B (Hib) infections and where the antigen is adsorbed onto aluminium phosphate. The invention also relates to a multivalent vaccines, that is a vaccine for the amelioration or treatment of more than one disease states. The present invention also relates to the production and use of such vaccines in medicine.
    Type: Application
    Filed: May 23, 2002
    Publication date: December 5, 2002
    Inventors: Julien Peetermans, Pierre Hauser
  • Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
    Publication number: 20020054884
    Abstract: The invention relates to a vaccine formulation for the prevention of Haemophilus Influenzae Type B (Hib) infections and where the antigen is adsorbed onto aluminium phosphate. The invention also relates to a multivalent vaccine, that is a vaccine for the amelioration or treatment of more than one disease states. The present invention also relates to the production and use of such vaccines in medicine.
    Type: Application
    Filed: September 13, 2001
    Publication date: May 9, 2002
    Applicant: SmithKline Beecham Biologicals, sa
    Inventors: Julien Peetermans, Pierre Hauser
  • Live influenza type B virus vaccines and preparation thereof
    Patent number: 3962423
    Abstract: Attenuated stable influenza type B virus strains are obtained by recombining a vaccinal and previously attenuated influenza type B virus strain with an influenza type B virus isolate having the desired serotype and isolating a recombinant having at least one marker property of the attenuated parent strain which is not shared by the other parent strain and the antigenic composition of the other parent strain. The obtained strains are useful for the production of nasal influenza vaccines.
    Type: Grant
    Filed: April 18, 1975
    Date of Patent: June 8, 1976
    Assignee: Recherche et Industrie Therapeutiques (R.I.T.)
    Inventors: Julien Peetermans, Michele Lobmann, Jean-Marie Prevost, Emil Vascoboinic
  • Live influenza virus vaccines and preparation thereof
    Patent number: 3953592
    Abstract: Stable H.sub.3 N.sub.2 influenza virus strains completely resistant to serum inhibitors are obtained by passaging at least one time in the allantoic cavity of embryonated eggs in the presence of serum a recombinant strain previously obtained from an H.sub.3 N.sub.2 influenza strain and the A/PR.sub.8 influenza virus strain and isolating the so-obtained serum inhibitors resistant strains. The obtained strains are useful for vaccine production.
    Type: Grant
    Filed: September 27, 1973
    Date of Patent: April 27, 1976
    Assignee: Recherche et Industrie Therapeutiques (R.I.T.)
    Inventor: Julien Peetermans